Sign in
4

Changes in Ownership

IRONWOOD PHARMACEUTICALS INC Filed Acc 0000950170-25-019235

SVP, CMO, Head-Res&Drug sold 41,269 shares at $1.76 ($72,633)

  • SVP, CMO, Head-Res&Drug acquired 133,333 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Shetzline Michael SVP, CMO, Head-Res&Drug 2025-02-10 Grant or award +133,333 595,276 D
Shetzline Michael SVP, CMO, Head-Res&Drug 2025-02-10 Sale −41,269 $1.76 $72,633 554,007 D
Open-market sales · 41,269 sh · avg $1.76 · $72,633
Loading xslF345X05/ownership.xml…